BiomarkersHuman trial

Using a proteomics-based test to assess cardiovascular risk in individuals with clonal hematopoiesis of indeterminate potential (CHIP)

AHA Scientific Sessions 2025 Abstract

The paper

Wommack J, Carpenter M, Chadwick J et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4366580

doi.org/10.1161/circ.152.suppl_3.4366580